Goro Katsuumi

1.2k total citations · 1 hit paper
32 papers, 660 citations indexed

About

Goro Katsuumi is a scholar working on Physiology, Molecular Biology and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Goro Katsuumi has authored 32 papers receiving a total of 660 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Physiology, 8 papers in Molecular Biology and 7 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Goro Katsuumi's work include Adipose Tissue and Metabolism (10 papers), Telomeres, Telomerase, and Senescence (8 papers) and Cancer, Hypoxia, and Metabolism (4 papers). Goro Katsuumi is often cited by papers focused on Adipose Tissue and Metabolism (10 papers), Telomeres, Telomerase, and Senescence (8 papers) and Cancer, Hypoxia, and Metabolism (4 papers). Goro Katsuumi collaborates with scholars based in Japan, United States and Denmark. Goro Katsuumi's co-authors include Tohru Minamino, Ippei Shimizu, Yohko Yoshida, Masayoshi Suda, Ryutaro Ikegami, Yoshitaka Hayashi, Tomoyoshi Soga, Yuka Hayashi, Shuang Jiao and Shujiro Okuda and has published in prestigious journals such as Circulation, PLoS ONE and Circulation Research.

In The Last Decade

Goro Katsuumi

29 papers receiving 655 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

SGLT2 inhibition eliminates senescent cells and alleviates pathological aging

2024 67 citations Goro Katsuumi, Ippei Shimizu et al. Nature Aging profile →

Peers

Countries citing papers authored by Goro Katsuumi

Since Specialization

Citations

This map shows the geographic impact of Goro Katsuumi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Goro Katsuumi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Goro Katsuumi more than expected).

Fields of papers citing papers by Goro Katsuumi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Goro Katsuumi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Goro Katsuumi. The network helps show where Goro Katsuumi may publish in the future.

Co-authorship network of co-authors of Goro Katsuumi

This figure shows the co-authorship network connecting the top 25 collaborators of Goro Katsuumi. A scholar is included among the top collaborators of Goro Katsuumi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Goro Katsuumi. Goro Katsuumi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Vaccination targeting senescence-associated transmembrane protein alleviated cardiovascular pathology in the mice 2024 ·European Heart Journal ·Chih‐Yen Hsiao, Goro Katsuumi, Yutaka Yoshida, Takaaki Furihata, Yusuke Joki, (unknown), (unknown), Hironori Nakagami, Tohru Minamino	0
2	SGLT2 inhibition eliminates senescent cells and alleviates pathological aging breakdown → 2024 ·Nature Aging ·Goro Katsuumi, Ippei Shimizu, Masayoshi Suda, Yohko Yoshida, Takaaki Furihata, Yusuke Joki, (unknown), Jiaqi Liang, (unknown), Manabu Abe, Masataka Sugimoto, Tomoyoshi Soga, Tohru Minamino	67
3	Potential Clinical Implications of Senotherapies for Cardiovascular Disease 2023 ·Circulation Journal ·Masayoshi Suda, Goro Katsuumi, Tamar Tchkonia, James L. Kirkland, Tohru Minamino	15
4	Glycoprotein nonmetastatic melanoma protein B regulates lysosomal integrity and lifespan of senescent cells 2022 ·Scientific Reports ·Masayoshi Suda, Ippei Shimizu, Goro Katsuumi, (unknown), Yohko Yoshida, Naomi Matsumoto, Yutaka Yoshida, Akihiro Katayama, Jun Wada, Masahide Seki, Yutaka Suzuki, Shujiro Okuda, Kazuyuki Ozaki, Mayumi Nakanishi‐Matsui, Tohru Minamino	45
5	Differing impact of phosphoglycerate mutase 1-deficiency on brown and white adipose tissue 2022 ·iScience ·Yohko Yoshida, Ippei Shimizu, (unknown), Masayoshi Suda, Goro Katsuumi, Masahide Seki, Yutaka Suzuki, Shujiro Okuda, Tomoyoshi Soga, Tohru Minamino	2
6	Endothelial SIRT-1 has a critical role in the maintenance of capillarization in brown adipose tissue 2022 ·iScience ·(unknown), Ippei Shimizu, Yohko Yoshida, Goro Katsuumi, Masayoshi Suda, Yoshiaki Kubota, Kenneth Walsh, Tohru Minamino	8
7	Coagulation factors promote brown adipose tissue dysfunction and abnormal systemic metabolism in obesity 2022 ·iScience ·Yuka Hayashi, Ippei Shimizu, Yohko Yoshida, Ryutaro Ikegami, Masayoshi Suda, Goro Katsuumi, (unknown), Kazuyuki Ozaki, Manabu Abe, Kenji Sakimura, Shujiro Okuda, Toshiya Hayano, Kazuhiro Nakamura, Kenneth Walsh, Naja Zenius Jespersen, Søren Nielsen, Camilla Schéele, Tohru Minamino	10
8	Cardiac mitofusin-1 is reduced in non-responding patients with idiopathic dilated cardiomyopathy 2021 ·Scientific Reports ·(unknown), Ippei Shimizu, (unknown), Yohko Yoshida, Ryutaro Ikegami, Yoshitaka Hayashi, Masayoshi Suda, Goro Katsuumi, (unknown), Takuya Ozawa, Daisuke Izumi, Takeshi Kashimura, Kazuyuki Ozaki, Tomoyoshi Soga, Tohru Minamino	22
9	Empagliflozin maintains capillarization and improves cardiac function in a murine model of left ventricular pressure overload 2021 ·Scientific Reports ·(unknown), Ippei Shimizu, Goro Katsuumi, Yohko Yoshida, Masayoshi Suda, Yuka Hayashi, Ryutaro Ikegami, (unknown), Shujiro Okuda, Tomoyoshi Soga, Tohru Minamino	29
10	Abstract 13736: Elimination of Senescent Cells Targeting Senescence Associated Glycoprotein (sagp) Improved the Atherosclerosis and Diabetes 2020 ·Circulation ·Masayoshi Suda, Ippei Shimizu, Goro Katsuumi, Yohko Yoshida, Yoshitaka Hayashi, Tohru Minamino	1
11	Role of smooth muscle cell p53 in pulmonary arterial hypertension 2019 ·PLoS ONE ·(unknown), Ippei Shimizu, Yohko Yoshida, Yuka Hayashi, Ryutaro Ikegami, Masayoshi Suda, Goro Katsuumi, (unknown), (unknown), Takeshi Kashimura, Kazufumi Nakamura, Hiroshi Ito, Takashi Nojiri, Tomoyoshi Soga, Tohru Minamino	32
12	p53 plays a crucial role in endothelial dysfunction associated with hyperglycemia and ischemia 2019 ·Journal of Molecular and Cellular Cardiology ·Masataka Yokoyama, Ippei Shimizu, Ayako Nagasawa, Yohko Yoshida, Goro Katsuumi, (unknown), Yoshitaka Hayashi, Ryutaro Ikegami, Masayoshi Suda, (unknown), Sho Okada, Marcus Fruttiger, Yoshio Kobayashi, Masanori Tsuchida, Yoshiaki Kubota, Tohru Minamino	44
13	Peptide vaccine for semaphorin3E ameliorates systemic glucose intolerance in mice with dietary obesity 2019 ·Scientific Reports ·Yohko Yoshida, Ippei Shimizu, Yoshitaka Hayashi, Ryutaro Ikegami, Masayoshi Suda, Goro Katsuumi, (unknown), (unknown), Hironori Nakagami, Ryuichi Morishita, Tohru Minamino	8
14	Boysenberry polyphenol inhibits endothelial dysfunction and improves vascular health 2018 ·PLoS ONE ·(unknown), Ippei Shimizu, Yohko Yoshida, Yuka Hayashi, Ryutaro Ikegami, Masayoshi Suda, Goro Katsuumi, (unknown), (unknown), Tohru Minamino	44
15	Vascular Senescence in Cardiovascular and Metabolic Diseases 2018 ·Frontiers in Cardiovascular Medicine ·Goro Katsuumi, Ippei Shimizu, Yohko Yoshida, Tohru Minamino	150
16	Gamma-Aminobutyric Acid Signaling in Brown Adipose Tissue Promotes Systemic Metabolic Derangement in Obesity 2018 ·Cell Reports ·Ryutaro Ikegami, Ippei Shimizu, Takeshi Sato, Yohko Yoshida, Yuka Hayashi, Masayoshi Suda, Goro Katsuumi, Ji Li, (unknown), Yasuhiko Minokoshi, Shiki Okamoto, Eiichi Hinoi, Søren Nielsen, Naja Zenius Jespersen, Camilla Schéele, Tomoyoshi Soga, Tohru Minamino	41
17	Inhibition of dipeptidyl peptidase-4 ameliorates cardiac ischemia and systolic dysfunction by up-regulating the FGF-2/EGR-1 pathway 2017 ·PLoS ONE ·Masayoshi Suda, Ippei Shimizu, Yohko Yoshida, Yoshitaka Hayashi, Ryutaro Ikegami, Goro Katsuumi, (unknown), Yutaka Yoshida, Shujiro Okuda, Tomoyoshi Soga, Tohru Minamino	18
18	The pathological role of vascular aging in cardio-metabolic disorder 2016 ·Inflammation and Regeneration ·Goro Katsuumi, Ippei Shimizu, Yohko Yoshida, Tohru Minamino	11
19	The effects of pure potassium channel blocker nifekalant and sodium channel blocker mexiletine on malignant ventricular tachyarrhythmias 2016 ·Journal of Electrocardiology ·(unknown), Kanae Hasegawa, Hiroshi Watanabe, Goro Katsuumi, Nobue Yagihara, Kenichi Iijima, Akinori Sato, Daisuke Izumi, Hiroshi Furushima, Masaomi Chinushi, Yoshifusa Aizawa, Tohru Minamino	7
20	p53-Induced inflammation exacerbates cardiac dysfunction during pressure overload 2015 ·Journal of Molecular and Cellular Cardiology ·Yohko Yoshida, Ippei Shimizu, Goro Katsuumi, Shuang Jiao, Masayoshi Suda, Yoshitaka Hayashi, Tohru Minamino	61

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact